CO5160252A1 - Proceso para preparar secretagogos de hormonas del crecimiento - Google Patents

Proceso para preparar secretagogos de hormonas del crecimiento

Info

Publication number
CO5160252A1
CO5160252A1 CO00012732A CO00012732A CO5160252A1 CO 5160252 A1 CO5160252 A1 CO 5160252A1 CO 00012732 A CO00012732 A CO 00012732A CO 00012732 A CO00012732 A CO 00012732A CO 5160252 A1 CO5160252 A1 CO 5160252A1
Authority
CO
Colombia
Prior art keywords
secretagogs
prepare
growth hormones
alkyl
jpeg
Prior art date
Application number
CO00012732A
Other languages
English (en)
Inventor
Frank Robert Busch
Charles Kwok-Fung Chiu
Nathaniel Meltz Clifford
Ronald James Post
Peter Robert Rose
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of CO5160252A1 publication Critical patent/CO5160252A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyridine Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Esta invención se refiere a procedimientos mejorados para preparar compuestos de fórmula II<EMI FILE="00012732_1" ID="1" IMF=JPEG >y compuestos de Fórmula III,<EMI FILE="00012732_2" ID="2" IMF=JPEG >en la que:R1 es -alquilo(C1-C10) opcionalmente sustituido con hasta tres átomos de flúor;R2 es fenilmetilo o 2-piridilmetilo;R3 es -alquil(C1-C5)-O-alquil(Co-C5)fenilo, estando el sustituyente fenilo en la definición de R3 opcionalmente sustituido con hasta tres átomos de flúor.
CO00012732A 1999-02-26 2000-02-23 Proceso para preparar secretagogos de hormonas del crecimiento CO5160252A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12274599P 1999-02-26 1999-02-26

Publications (1)

Publication Number Publication Date
CO5160252A1 true CO5160252A1 (es) 2002-05-30

Family

ID=22404505

Family Applications (1)

Application Number Title Priority Date Filing Date
CO00012732A CO5160252A1 (es) 1999-02-26 2000-02-23 Proceso para preparar secretagogos de hormonas del crecimiento

Country Status (44)

Country Link
US (2) US6541634B2 (es)
EP (2) EP1031575B1 (es)
JP (3) JP3437813B2 (es)
KR (2) KR100372063B1 (es)
CN (3) CN1137891C (es)
AP (1) AP1221A (es)
AR (2) AR029617A1 (es)
AT (1) ATE277944T1 (es)
AU (1) AU764122B2 (es)
BG (1) BG104175A (es)
BR (2) BRPI0000967B8 (es)
CA (1) CA2299495C (es)
CO (1) CO5160252A1 (es)
DE (1) DE60014212T2 (es)
DK (1) DK1031575T3 (es)
DZ (1) DZ3018A1 (es)
EA (1) EA003218B1 (es)
EE (1) EE200000193A (es)
ES (1) ES2226712T3 (es)
GT (1) GT200000018A (es)
HK (1) HK1030219A1 (es)
HN (1) HN2000000021A (es)
HR (1) HRP20000103A2 (es)
HU (1) HUP0000907A3 (es)
ID (1) ID24861A (es)
IL (2) IL157103A (es)
IN (1) IN192352B (es)
IS (1) IS5380A (es)
MA (1) MA25072A1 (es)
NO (1) NO20000965L (es)
NZ (1) NZ503062A (es)
OA (1) OA11325A (es)
PA (1) PA8491201A1 (es)
PE (1) PE20001550A1 (es)
PL (1) PL338628A1 (es)
PT (1) PT1031575E (es)
SG (1) SG90096A1 (es)
SI (1) SI1031575T1 (es)
SK (1) SK284982B6 (es)
TN (1) TNSN00035A1 (es)
TR (1) TR200000536A2 (es)
TW (2) TW200718702A (es)
UA (1) UA70306C2 (es)
ZA (1) ZA200000888B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1132388A3 (en) * 2000-03-09 2004-03-03 Pfizer Products Inc. Hexahydropyrazolo[4,3-c]pyridine metabolites
EP1289526A4 (en) 2000-05-30 2005-03-16 Merck & Co Inc MELANOCORTIN RECEPTOR AGONISTS
WO2004103983A1 (en) * 2003-05-26 2004-12-02 Biocon Limited Process for the preparation of s(+)-2-ethoxy-4-[n-{1-(2-piperidinophelyl)-3-methyl-1- butyl} aminocarbonylmethyl]benzoic acid derivatives
WO2005027913A1 (en) * 2003-09-19 2005-03-31 Pfizer Products Inc. Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and a growth hormone secretagogue
US9117477B2 (en) 2013-05-08 2015-08-25 HGST Netherlands B.V. Perpendicular magnetic recording media having novel seed layer
MX360906B (es) * 2013-05-28 2018-11-21 Raqualia Pharma Inc Forma cristalina del l-tartrato de 2-amino-n[2-(3a-(r)- bencil-2-metil-3-oxo-2,3,3a,4,6,7-hexahidro-pirazolo[4,3-c]piridi n-5-il)-1-(r)-benciloximetil-2-oxo-etil]-isobutiramida.
CN109320515A (zh) * 2018-11-22 2019-02-12 常州大学 一种Capromorelin手性中间体的不对称合成方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8610980D0 (en) 1986-05-06 1986-06-11 Ici America Inc Heterocyclic fused tricyclic compounds
GB8901423D0 (en) 1989-01-23 1989-03-15 Fujisawa Pharmaceutical Co Pyrazolopyridine compound and processes for preparation thereof
US5578593A (en) 1992-12-11 1996-11-26 Merck & Co., Inc. Spiro piperidines and homologs promote release of growth hormone
EP0739204A4 (en) 1993-11-09 2000-03-15 Merck & Co Inc PIPERIDINE, PYRROLIDINE AND HEXAHYDRO-1H-AZEPINE SUPPORT THE RELEASE OF THE GROWTH HORMONE
US5609150A (en) 1995-04-18 1997-03-11 Maged; Jeffrey M. Method for dilating respiratory passages
TW432073B (en) 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
AU2334097A (en) 1996-03-21 1997-10-10 Merck & Co., Inc. 4-spiroindoline piperidines promote release of growth hormone
WO1997036873A1 (en) 1996-04-03 1997-10-09 Merck & Co., Inc. Piperidines, pyrrolidines and hexahydro-1h-azepines promote release of growth hormone
UA64751C2 (uk) * 1997-06-25 2004-03-15 Пфайзер Продактс Інк. Спосіб лікування інсулінової толерантності речовинами, які посилюють секрецію гормону росту (варіанти) та фармацевтична композиція (варіанти)
JP3514774B2 (ja) 1997-06-25 2004-03-31 ファイザー・インク 成長ホルモン分泌促進薬としてのジペプチド誘導体
UA53716C2 (uk) 1997-06-25 2003-02-17 Пфайзер Продактс Інк. Тартратна сіль заміщеного дипептиду, спосіб її одержання, проміжні сполуки та спосіб їх одержання, фармацевтична композиція (варіанти), спосіб підвищення рівнів ендогенного гормону росту та спосіб лікування або профілактики захворювань (варіанти)

Also Published As

Publication number Publication date
HUP0000907A2 (en) 2001-03-28
EA200000172A2 (ru) 2000-08-28
JP2003261565A (ja) 2003-09-19
PL338628A1 (en) 2000-08-28
IL157103A (en) 2007-07-24
EE200000193A (et) 2000-10-16
EP1031575B1 (en) 2004-09-29
PA8491201A1 (es) 2001-04-30
ZA200000888B (en) 2001-08-23
IL134599A (en) 2006-12-10
UA70306C2 (en) 2004-10-15
JP4051314B2 (ja) 2008-02-20
AP1221A (en) 2003-11-03
ES2226712T3 (es) 2005-04-01
HUP0000907A3 (en) 2001-05-28
AR053722A2 (es) 2007-05-16
ID24861A (id) 2000-08-31
IS5380A (is) 2000-08-27
SK284982B6 (sk) 2006-03-02
GT200000018A (es) 2001-08-16
BRPI0017522A2 (es) 2009-12-22
KR20020065455A (ko) 2002-08-13
BRPI0000967A (pt) 2001-09-11
JP3437813B2 (ja) 2003-08-18
TW200718702A (en) 2007-05-16
BRPI0000967B1 (pt) 2012-06-12
IN192352B (es) 2004-04-10
CN1270960A (zh) 2000-10-25
NO20000965L (no) 2000-08-28
NO20000965D0 (no) 2000-02-25
ATE277944T1 (de) 2004-10-15
US6541634B2 (en) 2003-04-01
BRPI0000967B8 (pt) 2021-12-07
IL157103A0 (en) 2004-02-08
EP1031575A1 (en) 2000-08-30
SG90096A1 (en) 2002-07-23
CN1137891C (zh) 2004-02-11
EP1449842A1 (en) 2004-08-25
AR029617A1 (es) 2003-07-10
HK1030219A1 (en) 2001-04-27
KR100361783B1 (ko) 2002-11-22
IL134599A0 (en) 2001-04-30
PE20001550A1 (es) 2001-01-11
EA200000172A3 (ru) 2000-10-30
US20020002283A1 (en) 2002-01-03
MA25072A1 (fr) 2000-10-01
SK2302000A3 (en) 2000-11-07
HU0000907D0 (en) 2000-04-28
TWI286142B (en) 2007-09-01
AP2000001754A0 (en) 2000-03-31
KR100372063B1 (ko) 2003-02-14
HN2000000021A (es) 2001-02-02
KR20010006698A (ko) 2001-01-26
US20030158414A1 (en) 2003-08-21
US6673929B2 (en) 2004-01-06
NZ503062A (en) 2001-07-27
BRPI0017522B8 (pt) 2021-05-25
CA2299495C (en) 2010-06-15
DE60014212D1 (de) 2004-11-04
SI1031575T1 (en) 2005-02-28
EA003218B1 (ru) 2003-02-27
AU764122B2 (en) 2003-08-07
TR200000536A2 (tr) 2000-09-21
CN1515570A (zh) 2004-07-28
AU1947100A (en) 2000-08-31
PT1031575E (pt) 2004-11-30
OA11325A (en) 2003-10-27
HRP20000103A2 (en) 2001-04-30
DE60014212T2 (de) 2005-12-15
DZ3018A1 (fr) 2004-03-20
JP2003327585A (ja) 2003-11-19
TNSN00035A1 (fr) 2005-11-10
CA2299495A1 (en) 2000-08-26
JP2000247974A (ja) 2000-09-12
BRPI0017522B1 (pt) 2013-09-24
CN1837205A (zh) 2006-09-27
DK1031575T3 (da) 2005-01-03
BG104175A (bg) 2000-12-29

Similar Documents

Publication Publication Date Title
AR006720A1 (es) Un compuesto derivado de azahexano heterociclico, su uso para la preparacion de una composicion farmaceutica, procedimiento para prepararlo y una composicion farmaceutica que lo comprende
CO5390047A1 (es) Derivados de uk-2a
CO5140093A1 (es) Epotilonas c 21 modificadas
CO5261589A1 (es) Compuestos heterociclicos, su produccion y su utilizacion
EG24902A (en) Pyrimidine compounds and pests controlling composition containing the same
CY1108792T1 (el) Παραγωγα διοξανιου-2-αλκυλκαρβαμικου, η παρασκευη τους και η εφαρμογη τους στην θεραπευτικη αγωγη
CO5261616A1 (es) Inhibidores no peptidicos de la union celular dependientes de vla-4 utiles en el tratamiento de enfermedades inflamatorias, autoinmunes y respiratorias
MY116761A (en) Novel spiroazabicyclic heterocyclic compounds.
PE20061490A1 (es) Derivados de ciclohexanosulfonilo como inhibidores del transportador de glicina glyt1
CO5261607A1 (es) Nuevo uso
CO5170512A1 (es) Derivados de tetrahidroquinolin piperidina
TW200643139A (en) π-conjugated compound having cardo structure, process for preparing same and use of same
ES2106783T3 (es) 1-benzopiran-4-onas y 2-amino-1,3-benzoxacin-4-onas antiarterosclerosis y antitromboticas.
CO5271666A1 (es) Derivados de pirimidina
NZ332990A (en) oral pharmaceutical composition containing a H+, K+-atpase inhibitor having a extended blood plasma profile
CO5390082A1 (es) Compuestos organicos
BRPI0407841A (pt) inibidores heterocìclicos de quinase
CO5160252A1 (es) Proceso para preparar secretagogos de hormonas del crecimiento
CO5090829A1 (es) Compuestos organicos de la formula i, utiles como inhibido res de la proteina de transferencia de triglicerido microso mal y de la secrecion de la apolipoproteina b.
CO5130006A1 (es) Compuestos de pirazina
NO20071100L (no) 5-jodtetrazoler
CO5200762A1 (es) Preparacion de piperidin-4-onas sustituidas
CO5231155A1 (es) Benzoilciclohexanodionas substituidas
KR920012004A (ko) 광학 활성 1-아릴-알킬아민의 라세미화 방법
AR037098A1 (es) Proceso para preparar un compuesto intermediario derivado de halo alquil sulfona y compuestos intermediarios que se usan en dicho proceso